# Efficacy of Erlotinib for Brain Metastasis of Non-Small Cell Lung Cancer

> **NCT00663689** · PHASE2 · UNKNOWN · sponsor: **Guangdong Provincial People's Hospital** · enrollment: 45 (estimated)

## Conditions studied

- Non-Small Cell Lung Cancer
- Brain Metastases

## Interventions

- **DRUG:** erlotinib

## Key facts

- **NCT ID:** NCT00663689
- **Lead sponsor:** Guangdong Provincial People's Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2008-03
- **Primary completion:** 2011-03
- **Final completion:** 2012-01
- **Target enrollment:** 45 (ESTIMATED)
- **Last updated:** 2008-04-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00663689

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00663689, "Efficacy of Erlotinib for Brain Metastasis of Non-Small Cell Lung Cancer". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00663689. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*